- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 112.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 111.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 115.88M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $4.29M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $7.38M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $3.37M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $3.5M |
| Capex | Q1 2026 · Mar 31, 2026 | $30.28M |
| Capex | Q1 2026 · Mar 31, 2025 | $27.39M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $18.67M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $43.4M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $691.05M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $875.47M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $13.4M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $36.68M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $7.21M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $6.47M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $272.12M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $305M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $265.42M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $261.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $395.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $267.24M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $475.07M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $433.03M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.02B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.17B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $769.68M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $717.74M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.58B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.53B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $40M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $41.61M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.64M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$12.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $10.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$11.76M |